CD22 and diffuse large B-cell lymphoma: The diagnosis of DLBCL was confirmed by pathology, which demonstrated CD19 (50%+), CD22 (80%+), CD20 (80%+), Bcl-6 (60%+), Mum- 1(+), c-myc(40%+), and Ki-67 (60%+).